Try our Advanced Search for more refined results
ÃÛÌÒÊÓÆµ UK
-
April 23, 2025
Canal+ Can't Block Software Co.'s Cube TM In UK
French media giant Canal Plus has failed to convince the U.K. ÃÛÌÒÊÓÆµ Office that a Chinese software company's trademark 'Cubenergy' has too much in common with its own trademark '+ LE Cube.'
-
April 23, 2025
Philips Loses Bid To Block Dutch Rival's Toothbrush Design
A Dutch court on Wednesday rejected Philips' claim that a rival infringed its copyright and design protections over an electric toothbrush, ruling that the competing devices are sufficiently different.
-
April 23, 2025
Rockwell Wins Patent Over Computer-Linked Devices
Rockwell Automation won its bid to patent techniques for improving input-output devices, after European officials rejected a rival's claims that a feature to display statuses on a terminal was previously known.
-
April 23, 2025
UKIPO Not Corrupt For Rejecting Patent, Judge Rules
A judge has dismissed a case against the head of the U.K. ÃÛÌÒÊÓÆµ Office, finding that an inventor had waited years after his patent was rejected to bring baseless claims of malice and corruption.
-
April 23, 2025
Swiss Drug Developer Veraxa To List In US In $1.6B SPAC Deal
Swiss life sciences investor Xlife Sciences said Wednesday that its portfolio company, Veraxa Biotech, will merge with blank-check business Voyager Acquisition Corp. in a $1.64 billion deal to list on Nasdaq.
-
April 22, 2025
Academic Says Journal Infringed Nanotube Paper Copyright
An American bioengineering researcher argued at the start of a London trial Tuesday that a scientific journal had wrongly published a paper related to carbon nanotubes without her consent, urging the judge to rule that it had infringed her copyright.
-
April 22, 2025
Pornhub Owner Can't Use US Docs In UPC Feud With Dish
Europe's patent court has refused to let Pornhub's owner submit fresh arguments against DISH Technologies based on a U.S. case, ruling that the fact a related patent might be interpreted differently didn't matter here.Â
-
April 22, 2025
Moderna Can't Buy Time To Defend COVID Vax UPC Claim
The Unified Patent Court has refused to hand Moderna an extra month to file its defense against a claim that its COVID-19 vaccine infringed a drugmaker's patents in Europe.
-
April 22, 2025
Kodak Fails To Pause Sales Ban In UPC Dispute With Fujifilm
Kodak has lost its attempt to pause an order halting sales of its lithographic printing products, failing to convince an appeals panel at the Unified Patent Court that an earlier ruling that it infringed a Fujifilm patent had obvious flaws.
-
April 22, 2025
Nyetimber Sues Distillery In 'Product Of England' TM Row
English sparkling winemaker Nyetimber has hit a Devon distillery with a claim for trademark infringement, accusing the gin maker of benefiting from its established reputation by copying the wine producer's "Product of England" branding on its bottles and labels.
-
April 17, 2025
Coty Wins Bid To Block Gray Market Hugo Boss Perfume Sale
Multinational beauty brand Coty has convinced a Hague court to block a Benelux cosmetics company from selling bottles of Hugo Boss perfume that were not permitted for sale in the European Union.
-
April 17, 2025
Music Royalties Co. Hipgnosis Revives UK Fight With Manilow
British music royalties firm Hipgnosis can forge ahead with its unpaid royalties case against singer Barry Manilow in the U.K., after an appellate panel on Thursday overturned a pause imposed because of parallel proceedings in Los Angeles.
-
April 17, 2025
Goya Foods Not Reputable Enough To Nix Rival's 'Goya' TM
A Spanish olive oil maker has failed to stop a German consultancy from registering the trademark "Goya" over telecommunication services, after European officials found that shoppers wouldn't get confused because the companies' products were worlds apart.
-
April 17, 2025
Abbott Can't Nix Edwards Lifesciences Heart Valve Tech
Edwards Lifesciences has won its bid to patent a prosthetic heart valve, after European officials overturned a previous decision that the company was requesting protection beyond its original filing.
-
April 17, 2025
UK Litigation Roundup: Here's What You Missed In London
The past week in London has seen the producers of West End show "Elf the Musical" face a contract dispute, Korean biotech company ToolGen Inc. bring a fresh patents claim against pharma giant Vertex, and ousted car tycoon Peter Waddell bring a claim against the private equity firm that backed his business. Here, Law360 looks at these and other new claims in the U.K.
-
April 17, 2025
UPC Clarifies Rules On Saving Evidence In Sawing Wire Feud
The Unified Patent Court has declined to review an order that allowed a Chinese company to inspect and preserve evidence at its rivals' premises amid an infringement feud over a sawing wire patent, ruling that it was a necessary step.
-
April 16, 2025
Nippon Paint Loses Anti-Rust Car Paint Patent On AppealÂ
European officials have revoked a car paint-maker's patent for a rust-preventing mix, ruling that skilled inventors at the time would have found it obvious to make the Japanese company's composition.Â
-
April 16, 2025
3M Loses Patent Over Reflective Material For Road Markings
An appeals board revoked 3M's European patent over a reflective material that can be used in road markings, ruling in a decision issued Wednesday that it isn't inventive.
-
April 16, 2025
Swatch Nixes Birth Control Entrepreneur's 'Andro-Swatch' TM
Swiss watchmaker Swatch has convinced European trademark officials to extend the earlier rejection of a contraception device entrepreneur's bid for the trademark "Andro-Swatch" to prevent the mark's use for advertising and other business management-related services.
-
April 16, 2025
EUIPO Shuts Down Fraudsters With Copycat Domain Name
The European Union ÃÛÌÒÊÓÆµ Office has convinced a Czech arbitration court to cancel the domain name euipp.com, which the agency said is being used to trick people into thinking they are sending money to the bloc's genuine IP authority.
-
April 16, 2025
Solar Vehicle Biz Beats Challenge To 'Go Free' TM In UK
A Dutch company that charges vehicles with solar power has fought off a rival's challenge to its "Go Free" trademark, convincing U.K. officials that there is no risk of confusion with an existing "Go" sign.
-
April 15, 2025
Truck Aerodynamics Co. Slams Strikeout Bid In Patent Row
A truck aerodynamics company has hit back at a strikeout request brought by the competitor it is accusing of infringing a patent it owned by wrongly modifying its spoilers, arguing the case involves disputed facts and requires a trial.
-
April 15, 2025
Ideagen Says K10 Vision Misled Clients With False Product Ties
Audit software company Ideagen Ltd. has accused the former owners of a business it acquired for over £19 million ($25.1 million) of tricking clients into defecting to a rival startup through false claims of involvement in developing a key Ideagen product.
-
April 15, 2025
Google Blocks Chinese Tech Co.'s European 'Googtab' TM
Google has successfully blocked a Chinese company from registering the European trademark "Googtab," after trademark officials agreed that the public were likely to confuse the mark with the Silicon Valley giant's existing rights for "Google."
-
April 15, 2025
Ducati Can't Nix 'Monster' Energy TM For Virtual Bikes
British officials have granted Monster Energy a trademark for its name over goods that can be downloaded virtually, ruling that shoppers wouldn't think that they were somehow connected to Ducati's Monster-branded motorcycles.Â
Expert Analysis
-
Keys To Successful AI Patents In The US And Europe
Unsurprisingly, the World ÃÛÌÒÊÓÆµ Organization recently reported that patent filings for artificial intelligence inventions are increasing rapidly. Stakeholders should be mindful of maintaining quality during this filing surge, says Drew Schulte of Haley Guiliano LLP.
-
9 Ways To Prepare Your IP Rights For Brexit
Those with a European intellectual property portfolio should be considering how Brexit — scheduled for March 29 — will affect EU trademarks and registered community designs, says Paula Jill Krasny of Levenfeld Pearlstein LLC.
-
'Biosimilar V. Biosimilar' Patent Case May Be First Of Many
​While the idea of patent disputes between makers of follow-on drugs is nothing new​, the complaint recently filed by Coherus against Amgen in Delaware federal court is unique in that it pits one biosimilar developer against another, say attorneys with Goodwin Procter LLP.
-
UK Patent Law: Hot Topics Of 2018 And What's Ahead
English courts have been active in the past year, grappling with patent topics like plausibility and equivalents, and 2019 promises to be another exciting year as English patent lawyers await developments on obviousness, insufficiency and employee inventor compensation, says Jin Ooi of Kirkland & Ellis LLP.
-
Coordinating Patent Strategies Across PTAB And EPO
The positions, arguments and prior art raised in U.S. post-grant proceedings at the Patent Trial and Appeal Board may influence European Patent Office oppositions involving counterpart cases. Understanding the procedural similarities and differences between the two jurisdictions is key, says Drew Schulte of Haley Guiliano LLP.
-
New EU Patent Guidelines May Affect Companies' AI Strategy
As compared to the European Patent Office’s guidelines for artificial intelligence and machine learning — which take effect on Thursday — the U.S. eligibility framework may prove to be more favorable to innovators, say Jennifer Maisel and Eric Blatt of Rothwell Figg Ernst & Manbeck PC​​​​​​​.
-
ÃÛÌÒÊÓÆµ Caught In US-China Trade Crossfire
Earlier this year, President Donald Trump imposed tariffs on Chinese products as a response to China’s trade practices concerning technology transfer, intellectual property and innovation. The U.S.-Chinese trade war highlights the need to approach investments in China differently, taking a broad view of intellectual assets and looking beyond basic legal protection, says Holly White, a consultant at Rouse & Co.
-
Patent Eligibility Assessments: US Approach Vs. UK Approach
Techniques used to address questions of obviousness in the U.K. may prove useful to practitioners addressing questions of patent eligibility in the U.S., say Christopher Carroll and Charles Larsen of White & Case LLP.
-
Surveying The CRISPR Patent War
Following this week’s oral argument at the Federal Circuit in University of California v. Broad Institute, there has been a surge of interest in the long-running CRISPR patent dispute. There are battles raging on multiple fronts, particularly in Europe, with several more on deck in the U.S., and maybe even in China, says Michael Stramiello of Paul Hastings LLP.
-
UK Patent Ruling Sharpens Contrast With US Practice
The U.K. Court of Appeal's decision last month in Regeneron v. Kymab is significant because it aligns the U.K.’s approach to the assessment of insufficiency with that of the European Patent Office. It also highlights, for U.S. companies, the stricter standard to which patent specifications are subject in Europe, say Edward Kelly and Regina Sam Penti of Ropes & Gray LLP.
-
IP Considerations For UK Open Banking App Developers
Since January of this year, consumer-facing banks in the U.K. have been required to make customers' banking data available to authorized third parties in a standardized format. As competition between open banking app developers increases, intellectual property rights will become a key legal tool, say Rajvinder Jagdev and Peter Damerell of Powell Gilbert LLP.
-
The Case For Early Mediation Or Arbitration In IP Disputes
Alternative dispute resolution is one of the best ways to resolve disputes involving patents, copyright, trademark, trade secrets and other intellectual property issues. While not every situation lends itself to ADR, it is more accessible than many parties assume, says Jerry Cohen of Burns & Levinson LLP.
-
International Arbitration In 2018: A Year Of Rule Revisions
Though still in its relative infancy, 2018 is shaping up to be a year of arbitral institution rule updates. Neil Newing and Ryan Cable of Signature Litigation LLP explore some of the more innovative and trending rule changes expected or predicted this year.
-
A Look At Chemical Supplemental Examination Requests
If used strategically, supplemental examination at the U.S. Patent and Trademark Office can provide a powerful tool for chemical patent owners to add to their armamentarium of options for Orange Book-listed patents when conducting a due diligence analysis of their patent estate prior to Orange Book listing, say attorneys with Finnegan Henderson Farabow Garrett & Dunner LLP.
-
Cloud-Based Patent Claims — And How Providers Can Help
Cloud customers may be exposed to liability for open source technologies that are buried deep within their providers’ offerings. In-house legal teams and developers need to be aware of the risk of patent litigation and the extent to which cloud providers can help mitigate these risks, says R. Paul Zeineddin of Zeineddin PLLC.